Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT and Surgery in Non-small Cell Lung Cancer
NCT03348748Phase 1Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Dec 2017
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial in non-small cell lung cancer (NSCLC) (3 arms), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoint: Incidence of treatment-related grade 3-5 adverse events. Started Dec 2017; status: terminated.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03348748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348748.